Lab-growing cardiomyocytes have been transplanted into a human patient for the first time in medical history, according to a report from the Japan Times.

Cardiologist Nelson Mangione has reportedly been acquitted of sexual battery charges that first surfaced in September 2018.

The World Health Organization has formally declared novel coronavirus, the respiratory outbreak that originated in Wuhan, China, a global emergency.

The global cardiovascular drugs market is expected to reach $92.3 billion by 2026, according to a report from Acumen Research and Consulting.

Scientists have uncovered a potential new treatment for heart failure with preserved ejection fraction (HFpEF)—and it’s one that already exists.

An analysis of PARTNER 2 data published in the New England Journal of Medicine Jan. 29 suggests five-year post-op outcomes are similar among heart patients who undergo either transcatheter or surgical aortic valve replacement.

A 90-second chest scan could be a game-changer for triaging patients who present to the emergency department with undiagnosed chest pain, according to research out of Detroit.

Fresh data from the CDC’s National Center for Health Statistics suggests U.S. life expectancy is climbing for the first time since 2014—but heart disease remains the number-one threat to mortality in the country.

When the cardiac and neurovascular catheterization lab at Riverside University Health System Medical Center (RUHS-MC) treated its first patient last February, the opening represented many things to many people.

The FDA has cleared a series of AI algorithms designed by California tech company Eko to facilitate the detection of atrial fibrillation and heart murmurs.